Canada Markets closed

Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.53-0.13 (-2.30%)
At close: 04:00PM EST
5.53 0.00 (0.00%)
After hours: 04:01PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 37.81
52 Week Low 31.45
50-Day Moving Average 36.25
200-Day Moving Average 33.72

Share Statistics

Avg Vol (3 month) 3238.65k
Avg Vol (10 day) 3597.03k
Shares Outstanding 525.27M
Implied Shares Outstanding 6N/A
Float 89.46M
% Held by Insiders 14.42%
% Held by Institutions 184.99%
Shares Short (Oct 13, 2022) 4434.6k
Short Ratio (Oct 13, 2022) 42.18
Short % of Float (Oct 13, 2022) 41.84%
Short % of Shares Outstanding (Oct 13, 2022) 41.16%
Shares Short (prior month Sept 14, 2022) 4326.35k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21000:50
Last Split Date 3Nov 03, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-5,365.50%

Management Effectiveness

Return on Assets (ttm)-20.15%
Return on Equity (ttm)-33.77%

Income Statement

Revenue (ttm)1M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1M
EBITDA -53.16M
Net Income Avi to Common (ttm)-53.79M
Diluted EPS (ttm)-2.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)139.81M
Total Cash Per Share (mrq)5.51
Total Debt (mrq)1.44M
Total Debt/Equity (mrq)1.05
Current Ratio (mrq)23.59
Book Value Per Share (mrq)6.81

Cash Flow Statement

Operating Cash Flow (ttm)-43.21M
Levered Free Cash Flow (ttm)-24.85M